May
04
2021
Dissolving Film Quells Agitation in Schizophrenia, Bipolar Disorder
The investigative treatment BXCL501 was found to be effective at reducing agitation in schizophrenia and bipolar disorder, the phase III SERENITY I and II trials found. In the first trial...